1V-LSD "VALERIE"
9.10€

Ro5-4864 is a synthetic compound that has garnered significant attention in the scientific community due to its unique properties and potential applications. This molecule is a member of the benzodiazepine class, studied primarily for its chemical structure and receptor-binding properties.
Ro5-4864, also known as 4'-chlorodiazepam, is structurally similar to other benzodiazepines but with distinct characteristics. Its chemical formula is C16H12ClN2O, featuring a chlorine atom at the 4' position of the phenyl ring. This structural modification gives Ro5-4864 unique binding properties, particularly its high affinity for peripheral benzodiazepine receptors (PBRs), now known as translocator protein (TSPO).
Unlike traditional benzodiazepines that primarily target central nervous system receptors, Ro5-4864 exhibits a strong affinity for TSPO, which is predominantly found in peripheral tissues and mitochondrial membranes. This specificity has led researchers to explore its potential in various fields, including:
As research progresses, Ro5-4864 continues to intrigue scientists with its distinctive pharmacological profile and potential therapeutic applications.
Ro5-4864 shows promise in the treatment of various neurological conditions. Its ability to modulate TSPO (Translocator Protein) activity may offer neuroprotective effects, potentially benefiting patients with neurodegenerative diseases such as Alzheimer's or Parkinson's. Researchers are exploring its capacity to reduce neuroinflammation and oxidative stress, key factors in these disorders.
The anxiolytic properties of Ro5-4864 make it a candidate for treating anxiety disorders. It interacts with GABA receptors, and research has primarily focused on its chemical structure and receptor-binding properties rather than confirmed therapeutic effects. However, further clinical trials are necessary to establish its efficacy and safety profile in these applications.
Emerging studies suggest Ro5-4864 might play a role in cancer therapy. Its ability to induce apoptosis in certain cancer cell lines has piqued interest among oncology researchers. While still in early stages, investigations are underway to determine its potential as an adjunct treatment in combination with traditional chemotherapies.
Preliminary research indicates that Ro5-4864 may have cardioprotective effects. Its anti-inflammatory properties could potentially reduce the risk of atherosclerosis and other cardiovascular diseases. Scientists are examining its impact on endothelial function and vascular inflammation, which could lead to novel therapeutic strategies for heart health.
Ro5-4864, a synthetic compound, primarily functions as a peripheral benzodiazepine receptor (PBR) ligand. This unique characteristic sets it apart from classical benzodiazepines, which typically target central nervous system receptors. Ro5-4864 binds with high affinity to PBRs, also known as translocator protein 18 kDa (TSPO), located predominantly on the outer mitochondrial membrane of various cell types.
Upon binding to PBRs, Ro5-4864 initiates a cascade of cellular responses. It modulates steroidogenesis, particularly in steroid-producing cells, by facilitating the transport of cholesterol across mitochondrial membranes. This process is crucial for the synthesis of neurosteroids, which play vital roles in neuronal function and neuroprotection.
Research suggests that Ro5-4864's interaction with PBRs may have implications for various physiological processes. Its ability to influence mitochondrial function and steroid production has sparked interest in its potential therapeutic applications. These may include neuroprotection, anxiety reduction, and modulation of inflammatory responses. However, it's important to note that further studies are needed to fully elucidate its effects and safety profile in clinical settings.
Researchers are actively exploring the potential neuroprotective effects of Ro5-4864. Several preclinical studies have shown promising results in animal models of neurodegenerative diseases. These investigations focus on the compound's ability to modulate neuroinflammation and oxidative stress, two key factors in the progression of conditions like Alzheimer's and Parkinson's disease.
Clinical trials are underway to evaluate Ro5-4864's efficacy in treating anxiety and stress-related disorders. Scientists are particularly interested in its potential as an alternative to traditional benzodiazepines, given its unique pharmacological profile. These studies aim to assess both the short-term anxiolytic effects and the long-term safety of Ro5-4864 in human subjects.
Recent research has uncovered potential anti-cancer properties of Ro5-4864. In vitro studies have demonstrated its ability to induce apoptosis in certain cancer cell lines. Ongoing investigations are examining the compound's effects on tumor growth and metastasis in animal models. These findings could pave the way for future clinical trials exploring Ro5-4864 as a novel cancer therapeutic agent.
As research on Ro5-4864 progresses, scientists are uncovering its potential for various therapeutic applications. This compound's unique properties make it a promising candidate for treating neurological disorders and inflammatory conditions. Studies suggest that Ro5-4864 may have neuroprotective effects, potentially benefiting patients with neurodegenerative diseases such as Alzheimer's or Parkinson's.
The exploration of Ro5-4864 is paving the way for innovative drug development strategies. Researchers are investigating how this compound interacts with cellular mechanisms, which could lead to the creation of more targeted and effective medications. This advancement may revolutionize treatment approaches for anxiety disorders, epilepsy, and other neurological conditions.
While the potential of Ro5-4864 is exciting, scientists face challenges in fully understanding its mechanisms and optimizing its use. Further research is needed to elucidate its long-term effects and potential side effects. However, these challenges also present opportunities for interdisciplinary collaboration and scientific innovation. As our knowledge of Ro5-4864 expands, so does the possibility of developing safer, more effective treatments for a range of medical conditions.
This product is for laboratory research only, strictly not for human consumption DISCLAIMER: BY CONTINUING TO PURCHASE THE PRODUCT, THE CUSTOMER ACKNOWLEDGES AND AGREES THAT THIS PRODUCT IS NOT FOR HUMAN CONSUMPTION, DOES NOT CONSTITUTE MEDICINE, AND MUST NOT BE USED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE, NOR TO ACHEIVE ANY OTHER EFFECTS ON THE HUMAN BODY. ALL RESEARCH CHEMICALS ARE OFFERED SOLELY FOR LIGITIMATE LABORATORY RESEARCH PURPOSES AND MAY STILL BE UNDERGOING SCIENTIFIC RESEARCH, TO DETERMINE THEIR SAFETY.


| Product Details | |
| Brand | Research Chemicals |
| Quantity | |
|---|---|
| 25 - 49 | 2.06€ |
| 50 - 99 | 1.94€ |
| 100+ | 1.71€ |
What other customers are buying right now